BamSEC and AlphaSense Join Forces
Learn More

Minerva Neurosciences Inc – Material Contracts

NASDAQ: NERV    
Share price (8/6/26): $4.44    
Market cap (8/6/26): $207 million

Material Contracts Filter

EX-10.2
from 8-K 16 pages Consultancy Agreement (1) Minerva Neurosciences, Inc. (2) Geoff Race
12/34/56
EX-10.1
from 8-K 23 pages Dated 30 March 2026 Settlement Agreement Between Mind-Nrg Sarl and Minerva Neurosciences, Inc. and Geoff Race
12/34/56
EX-10.10
from 10-K 3 pages Amended and Restated Non-Employee Director Compensation Plan Last Amended on December 22, 2025
12/34/56
EX-10.1
from 8-K 23 pages Minerva Neurosciences, Inc. Amended and Restated 2013 Equity Incentive Plan Adopted by Board of Directors On: December 19, 2013 Approved by the Stockholders On: December 19, 2013 Amended and Restated by the Board of Directors On: April 29, 2014 Amendment and Restatement Approved by the Stockholders On: June 2, 2014 Amended and Restated by the Board of Directors On: April 21, 2018 Amendment and Restatement Approved by the Stockholders On: June 7, 2018 Amended and Restated by the Board of Directors On: April 17, 2020 Amendment and Restatement Approved by the Stockholders On: June 19, 2020 Amended and Restated by the Board of Directors On: July 30, 2023 Amendment and Restatement Approved by the Stockholders On: September 27, 2023 Amended and Restated by the Board of Directors On: November 14, 2025 Amendment and Restatement Approved by the Stockholders On: December 22, 2025 ***
12/34/56
EX-10.1
from 8-K 10 pages Consulting Agreement
12/34/56
EX-10.2
from 8-K 4 pages Support Agreement
12/34/56
EX-10.1
from 8-K 59 pages Securities Purchase Agreement
12/34/56
EX-10.12
from 10-K/A 1 page Amended and Restated Non-Employee Director Compensation Plan
12/34/56
EX-10.12
from 10-K/A 2 pages Amended and Restated Non-Employee Director Compensation Plan
12/34/56
EX-10.2
from 10-Q 33 pages Minerva Neurosciences, Inc. Amended and Restated 2013 Equity Incentive Plan
12/34/56
EX-10.1
from 10-Q 3 pages Amended and Restated Non-Employee Director Compensation Plan
12/34/56
EX-10.1
from 8-K 34 pages Securities Purchase Agreement
12/34/56
EX-10
from 10-K 5 pages Second Amendment to the Employment Agreement of Remy Luthringer
12/34/56
EX-10.1
from 8-K 3 pages First Amendment to the Employment Agreement of Remy Luthringer
12/34/56
EX-10.2
from 8-K 15 pages October 11th, 2021 Fred Ahlholm 48 Hawkins Lane North Andover, Ma 01842 Re: Amended and Restated Employment Agreement Dear Fred, Minerva Neurosciences, Inc. (The “Company”) Is Pleased to Offer You Continued Employment on the Terms Set Forth in This Letter Agreement (The “Agreement”)
12/34/56
EX-10.1
from 8-K 3 pages First Amendment to the Employment Agreement of Geoff Race
12/34/56
EX-10.1
from 8-K 18 pages September 2, 2021 Jay B. Saoud 271 Pepperell Road Groton, Ma 01450 Re: Transition, Separation, and Consulting Agreement Dear Jay: This Letter Sets Forth the Terms of the Transition, Separation, and Consulting Agreement (The “Agreement”) That Minerva Neurosciences, Inc. (The “Company”) Is Offering to You to Aid in Your Transition
12/34/56
EX-10.3
from 10-Q 2 pages April 27, 2021 Re:supplemental Retention Benefit
12/34/56
EX-10.2
from 10-Q 2 pages April 27, 2021 Geoff Race [•••] Re:supplemental Retention Benefit
12/34/56
EX-10.1
from 10-Q 2 pages April 27, 2021 Remy Luthringer, Phd [•••] Re:supplemental Retention Benefit
12/34/56